Overview

Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
0
Participant gender:
All
Summary
The use of the Percutaneous Isolated Limb Procedure (PILP) which enables the use of existing antibiotic therapies in a more targeted and concentrated fashion in patients with diabetes who have a significant lower limb infection and it is deemed that IV antibiotics are needed in order to salvage the limb or life.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Osprey Medical, Inc
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Clavulanic Acid
Clavulanic Acids
Ticarcillin
Ticarcillin-clavulanic acid
Criteria
Inclusion Criteria:

- M or F subjects 18 - 90 years old

- Subject has pre-existing diabetes diagnosis

- Subject has significant infection below the ankle of soft tissue and may include bone,
and IV antibiotics are needed in order to salve limb or life

- Consequence of infected wound would require Std of Care share debridement

- Subject willing and able to provide written informed consent

- Subject willing and able to comply with requirements of study protocol including
pre-defined follow-up evaluations

- PROCEDURAL INCLUSION CRITERIA: successful cannulation of the femoral artery and vein
and placement of the venous support device

Exclusion Criteria:

- Allergy to contrast media

- Known bleeding disorder including thrombocytopenia

- Recent AMI or elevated Troponin levels within last 30 days

- Penicillin sensitivity; Timentin sensitivity

- Female subjects known to be or suspected to be pregnant or lactating

- Subject unable to comply with instructions; especially to remain supine for duration
of recirculation procedure

- Subjects who have participated in any other clinical trial or taken investigational
drug within 30 days of study enrollment

- The PI determines the subject is not an appropriate subject for the study

- PROCEDURAL EXCLUSION CRITERIA: Subjects anatomy interferes with or is expected to
prohibit successful cannulation of the femoral vessels or placement of the venous
support device

- Known severe proximal femoral artery vascular disease precluding placement of
perfusion catheters